Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks
Corresponding Author
M. Ilyas Kamboh
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, 624 Parran Hall, Pittsburgh, PA 15261===Search for more papers by this authorClareann H. Bunker
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Search for more papers by this authorChristopher E. Aston
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Search for more papers by this authorCara S. Nestlerode
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Search for more papers by this authorAndrea E. McAllister
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Search for more papers by this authorFlora A. Ukoli
Department of Community Health, University of Benin Teaching Hospital, Benin City, Nigeria
Search for more papers by this authorCorresponding Author
M. Ilyas Kamboh
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, 624 Parran Hall, Pittsburgh, PA 15261===Search for more papers by this authorClareann H. Bunker
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Search for more papers by this authorChristopher E. Aston
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Search for more papers by this authorCara S. Nestlerode
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Search for more papers by this authorAndrea E. McAllister
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
Search for more papers by this authorFlora A. Ukoli
Department of Community Health, University of Benin Teaching Hospital, Benin City, Nigeria
Search for more papers by this authorAbstract
Genetic studies carried out mainly in European and European-derived populations have shown that common polymorphisms in genes coding for apolipoproteins are significant determinants of serum lipoprotein-lipid levels variation. However, except for a few sporadic studies, the distribution of apolipoprotein polymorphisms and their association with serum lipoprotein-lipid levels have not been evaluated systematically in African or African-derived populations. In this investigation we have studied five apolipoprotein polymorphisms, including APOA1/MspI –75 bp, APOA1/MspI +83 bp, APOC3/PvuII, APOE, and APOH in 786 Africans (493 men, 293 women) from Nigeria. The sample is comprised of Nigerian civil servants consisting of 462 junior staff (less affluent) and 324 senior staff (more affluent) where staff status is a correlate of their socioeconomic status. We first examined genetic associations in the total sample stratified by gender to determine the role of apolipoprotein polymorphisms in affecting serum lipid profile in the general population, and then by staff status to evaluate possible gene-environment interactions. In the total sample, the APOC3/PvuII polymorphism showed significant effect on HDL-cholesterol (P = 0.029) and HDL3-cholesterol (P = 0.009) in women, and the APOE polymorphism was significantly associated with total cholesterol (P = 0.031) and LDL-cholesterol (P = 0.0006) in women. Multiple regression analyses showed that the APOC3/PvuII polymorphism accounts for about 2 and 3% of the variation in HDL-cholesterol and HDL3-cholesterol, respectively, in women; while the APOE polymorphism accounted for about 5 and 6% of the variation in total- and LDL-cholesterol, respectively, in women. Whereas the association of the APOE polymorphism was independent of the staff status, the significant affect of the APOC3/PvuII polymorphism on HDL- and HDL3-cholesterol was confined to senior staff women where it explained about 7% of their variation. We also observed an interaction between staff and the APOH polymorphism in affecting cholesterol levels. The APOH polymorphism showed significant association with total cholesterol (P = 0.010) and LDL-cholesterol (P = 0.016) in senior staff women and explained about 7 and 5% of their phenotypic variations, respectively. These data indicate that gene-environment interaction may play an important role in affecting serum lipid profile in African populations. Genet. Epidemiol. 16:205–222, 1999. © 1999 Wiley-Liss, Inc.
References
- Barre DE, Guerra R, Vertraete R, Wang Z, Grundy SM, Cohen JC. 1994. Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HLD-cholesterol levels. J Lipid Res 35: 1292–1296. Medline
- Boerwinkle E, Sing CF. 1986. Biases of contribution of single-locus effects to the variance of quantitative trait. Am J Hum Genet 39: 137–144. Medline
- Breslow J. 1988. Apolipoprotein genetic variation and human disease. Physiol Rev 68: 85–132. Medline
- Bunker CH, Ukoli FA, Okoro FI, Olomu AB, Kriska AM, Houston SL, Markovic N, Kuller LH. 1996. Correlate of serum lipids in a lean black population. Atherosclerosis 123: 215–225. Medline
- Cassader M, Ruiu G, Gambino R, Guzzon F, Dagano A, Vegalia F, Pagni R, Pagagno G. 1994. Influence of apolipoprotein H polymorphism on levels of triglycerides. Atherosclerosis 110: 45–51. Medline
- Chakraborty R, Kamboh MI, Nwankwo M, Ferrell RE. 1992. Caucasian genes in blacks: new data. Am J Hum Genet 50: 145–155. Medline
- Cooper ES, Kuller LH, Saunders E, Martinez-Maldonado M, Caplan LR, Yatsu FM, Savage DD, Curry CL, Yu PN, Shulman NB, Hall WD. 1991. Cardiovascular diseases and stroke in African-Americans and other racial minorities in the United States. A statement for health professionals. Circulation 83: 1462–1480.
- Davignon J, Gregg RE, Sing CF. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1–21. Medline
- De Knijff P, Johansen LG, Rossenen M, Frants RR, Jesperson J, Havekes LM. 1992. Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, apoE and A4 polymorphisms, and lifestyle. Arterioscler Thromb 12: 1371–1379. Medline
- De Knijff P, Boomsma DI, Wit Ed, Kempen HJM, Leuven JAG, Frants RR, Havekes LM. 1993. The effect of the apolipoprotein E phenotype on plasma lipid is not influenced by environmental variability: results of a Dutch twin study. Hum Genet 91: 268–272. Medline
- Dischinger P, Duchene AG. 1986. Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial. Controlled Clin Trials 7: 137S–157S. Medline
- Eichner JE, Kuller LH, Ferrell RE, Meilahn EN, Kamboh MI. 1990. Phenotypic effects of apolipoproteins structural variation on lipid profiles. III. The contribution of APO E to prediction of total cholesterol, APO B and LDL-C in the Healthy Women Study. Arteriosclerosis 10: 379–385. Medline
- Friedewald WT, Levy RI, Frederickson DS. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18: 499–503. Medline
- Gillum RF. 1982. Coronary heart disease in black populations. I. Mortality and morbidity. Am Heart J 104: 839–851. Medline
- Gillum RF. 1985. The epidemiology of coronary heart disease in blacks. J Natl Med Assoc 77: 281. Medline
- Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Utermann G. 1991. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49: 338–349. Medline
- Hanis CL, Hewett-Emmett D, Douglas TC, Bertin TK, Schull J. 1991. Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins and apolipoproteins among Mexican-Americans in Starr County, Texas. Arterioscler Thromb 11: 362–370. Medline
- Hixson JE. 1991. The pathological determinants of atherosclerosis in youth (PDAY) Research Group. Apolipoprotein E polymorphism affects atherosclerosis in young males. Arterioscler Thromb 11: 1237–1244. Medline
- Humphries SE. 1988. DNA polymorphism of the apolipoprotein gene: their use in investigating the genetic component of hyperlipidemia and atherosclerosis. Atherosclerosis 72: 89–108. Medline
- Islam S, Gutin B, Smith C, Trieber F, Kamboh MI. 1994. Association of apolipoprotein (a) phenotypes in children with family history of premature coronary artery disease. Arterioscler Thromb 14: 1609–1616. Medline
- Jeenah M, Kessling A, Miller N, Humphries SE. 1990. G to A substitution in the promoter region of the apolipoprotein A-I gene is associated with elevated serum apolipoprotein A-I and high density lipoprotein cholesterol concentrations. Mol Biol Med 7: 233–241. Medline
- Jeamae R, Fumeron F, Poirer O, Lecert L, Evans A, Arveiler D, Luc G. 1995. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 36: 2141–2146.
- Kamboh MI, Ferrell RE, Sepehrnia B. 1988. Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (B2-glycoprotein-I). Am J Hum Genet 42: 452–457. Medline
- Kamboh MI, Ferrell RE. 1991. Apolipoprotein H polymorphism and its role in lipid metabolism. Adv Lipid Res 1: 9–18.
- Kamboh MI, Weiss KM, Ferrell RE. 1991. Genetic studies of human apolipoproteins. XVI. ApoE polymorphism and cholesterol levels in the Mayans of the Yucatan Peninsula, Mexico. Clin Genet 39: 26–32. Medline
- Kamboh MI, Hamman RF, Ferrell RE. 1992. Two polymorphisms in the APO A-IV coding gene: their evolution and linkage disequilibrium. Genet Epidemiol 9: 305–315.
- Kamboh MI, Aston CE, Hamman RF. 1995a. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis 112: 145–159. Medline
- Kamboh MI, Wegenknecht DR, McIntyre JA. 1995b. Heterogeneity of the apolipoprotein H*3 allele and its role in affecting the binding of apolipoprotein H (B2-glycoprotein I) to anionic phospholipids. Hum Genet 95: 385–388. Medline
- Kamboh MI, Aston CE, Svitko CM, McAllister AE, Hamman RF. 1996a. Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apoA-I and HDL-cholesterol. Atherosclerosis 127: 255–262. Medline
- Kamboh MI, Crawford MH, Aston CE, Leonard WR. 1996b. Population distributions of APOE, APOH, and APOA4 polymorphisms and their relationships with quantitative plasma lipid levels among the Evenki Herders of Siberia. Hum Biol 68: 231–243. Medline
- Kaprio J, Ferrell RE, Kottke BA, Sing CF. 1989. Smoking and reverse cholesterol transport: evidence for gene-environment interaction. Clin Genet 36: 266–268. Medline
- Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. 1991. Effects of polymorphisms in apolipoproteins E, A-IV and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 11: 1330–1348. Medline
- Kriska AM, Knowler WC, LaPorte RE, Drash AL, Wing RR, Blair SN, Bennett PH, Kuller LH. 1990. Development of a questionnaire to examine the relationship of physical activity and diabetes in the Pima Indians. Diabetes Care 13: 401–411. Medline
- Mattu RK, Needham EWA, Ruth M, Rees A, Hackshaw AK, Stocks J, Elwood PC, Galton DJ. 1994. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 14: 1090–1097. Medline
- Minnich A, De Langavant G, Lavigne J, Roederer G, Lussier-Cacan S, Davignon J. 1995. G→A substitution at position –75 of the apolipoprotein A-I gene promoter. Evidence against a direct effect on HDL cholesterol levels. Arterioscler Thromb Vas Biol 15: 1740–1745. Medline
- Needham EWS, Mattu RK, Rees A, Galton DJ. 1994. A polymorphism in the human apolipoprotein AI promoter region: a study in hypertriglyceridaemic patients. Hum Hered 44: 94–99. Medline
- Patsch W, Sharrett R, Chen LY, Lin-Lee Y, Spencer AB, Gotto AM Jr, Boerwinkle E. 1994. Association of allelic differences at the A-I/C-III/A-IV gene cluster with carotid artery intima media thickness and plasma lipid transport in hypercholesterolemic-hypertriglyceridemic humans. Arterioscler Thromb 14: 874–883. Medline
- Paul-Hayase F, Rossenneu M, Robinson D, Van Bervliet J, Deslypere JP, Humphries SE. 1992. Polymorphisms in the apolipoprotein (apo) A-I-C-III-A-IV gene cluster: detection of genetic variation determining plasma apo A-I, apo C-III and apo A-IV concentrations. Hum Genet 88: 439–446. Medline
- Saha N, Tay JSH, Low PS, Humphries SE. 1994. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI gene levels in Chinese non-smokers. Genet Epidemiol 11: 255–264. Medline
- Sandholzer C, Delport R, Vermaak H, Utermann G. 1995. High frequency of the apo ϵ4 allele in Khoi San from South Africa. Hum Genet 95: 46–48. Medline
- Sanghera DK, Wegenknecht DR, McIntyre JA, Kamboh MI. 1997. Identification of structural mutations in the fifth domain of apolipoprotein H (B2-glycoprotein I) which affect phospholipid binding. Hum Mol Genet 6: 311–316. Medline
- Sepehrnia B, Kamboh MI, Adams-Campbell LL, Bunker CH, Nwankwo M, Majumder PP, Ferrell RE. 1989. Genetic studies of human apolipoproteins. VIII. Role of the apolipoprotein H polymorphism in relation to serum lipoprotein concentrations. Hum Genet 82: 118–122. Medline
- Sigurdsson J, Gudnason V, Sigurdsson G, Humphries SE. 1992. Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I. Arterioscler Thromb 12: 1017–1022. Medline
- Smith JD, Brinton EA, Breslow J. 1992. Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest 89: 1796–1800. Medline
- Talmud PJ, Ye S, Humphries SE, EARS Group. 1994. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study. Genet Epidemiol 11: 265–280.
- Templeton AR. 1987. The general relationship between average effect and average excess. Genet Res Camb 49: 69–70.
- Tiret L, de Kniff P, Menzel HJ, Ehnholm C, Nicuad V, Havekes LM. 1994. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations; The EARS Study. Arterioscler Thromb 14: 1617–1624. Medline
- Utermann G. 1987. Apolipoprotein E polymorphism in health and disease. Am Heart J 113: 433–440. Medline
- Wang XL, Badenhop R, Humphrey KE, Wilcken DEL. 1996a. New MspI polymorphism at +83 of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol 13: 1–10.
- Wang XL, Liu S, McCredie RM, Wilcken DEL. 1996b. Polymorphisms at the 5′-end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest 98: 372–377. Medline
- Wiseman SA, Powell JT, Barber N, Humphries SE, Greenhalgh RM. 1991. Influence of apolipoproteins on the anatomical distribution of arterial disease. Atherosclerosis 89: 231–237. Medline
- Xu C, Angelico F, Del Ben M, Humphries SE. 1993. Role of genetic variation at the apo A-I-C-III-A-IV gene cluster in determining plasma apo A-I levels in boys and girls. Genet Epidemiol 10: 113–122.
- Xu CF, Nanjee MN, Savill J, Talmud PJ, Angelico F, Ben MD, Antonini R, Mazzarella B, Miller N, Humphries SE. 1990. Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apolipoprotein levels in Italian children. Am J Hum Genet 47: 429–439. Medline
- Zekraoui L, Lagarde JP, Raisonnier A, Gerard N, Aouizerate Aouizerate, Lucotte G. 1997. High frequency of the apolipoprotein E*4 allele in African pygmies and most of the African populations in sub-Saharan Africa. Hum Biol 69: 575–581. Medline